TP53 and prostate cancer: Another study examined the anti-tumorigenic effects of inulanolide A in prostate cancer, showing its ability to inhibit migration, invasion, and proliferation of prostate cancer cells, regardless of androgen receptor (AR) responsiveness and p53 status.